He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.

A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

There are many symptoms that are common to a wide variety of diseases, like fever, which can indicate an infection, autoimmune disease, or ... | Clinical And Molecular Dx ...

MaxCyte's technology will support TG Therapeutics' efforts to develop a CD19 CAR-T cell therapy program for autoimmune diseases.

The Korea Research Institute of Standards and Science (KRISS) has developed a safety evaluation technology for nanoparticles* ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...